We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

47 hedge funds and large institutions have $219M invested in Taro Pharmaceutical Industries Ltd. in 2013 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 4

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

62% more capital invested

Capital invested by funds: $136M → $219M (+$83.5M)

38% more funds holding

Funds holding: 34 → 47 (+13)

15% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 13

Holders
47
Holders Change
+13
Holders Change %
+38.24%
% of All Funds
1.52%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.16%
New
17
Increased
11
Reduced
13
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management
California
+$28.5M
2
CCM
Consonance Capital Management
New York
+$8.17M
3
KCM
Kennedy Capital Management
Missouri
+$5.03M
4
Renaissance Technologies
Renaissance Technologies
New York
+$3.24M
5
MCP
Moab Capital Partners
New York
+$2.08M

Top Sellers

1
RCM
Raging Capital Management
New Jersey
-$14.7M
2
AA
Ancient Art
Texas
-$4.92M
3
Two Sigma Investments
Two Sigma Investments
New York
-$568K
4
ACM
Ativo Capital Management
Illinois
-$391K
5
Deutsche Bank
Deutsche Bank
Germany
-$267K
Name Holding Trade Value Shares
Change 		Change in
Stake
MC
26
Menta Capital
California
$331K – – –
TCM
27
Touradji Capital Management
Florida
$327K -$13K -200 -4%
BFA
28
BlackRock Fund Advisors
California
$304K +$31K +477 +14%
HIM
29
Hillsdale Investment Management
Ontario, Canada
$296K +$253K +3,900 New
WAM
30
World Asset Management
Michigan
$295K -$46.7K -720 -16%
HHC
31
Hutchin Hill Capital
New York
$274K +$234K +3,600 New
PP
32
PDT Partners
New York
$250K -$206K -3,169 -49%
State Street
33
State Street
Massachusetts
$230K +$197K +3,037 New
FSC
34
Fiduciary Services Corp
Georgia
$225K +$192K +2,955 New
SC
35
Scotia Capital
Ontario, Canada
$224K +$191K +2,950 New
Comerica Bank
36
Comerica Bank
Texas
$212K +$181K +2,791 New
Nomura Holdings
37
Nomura Holdings
Japan
$203K -$155K -2,389 -47%
Dimensional Fund Advisors
38
Dimensional Fund Advisors
Texas
$147K +$125K +1,929 New
Wells Fargo
39
Wells Fargo
California
$72K +$19.3K +298 +46%
TFMS
40
Trust & Fiduciary Management Services
Massachusetts
$63K – – –
Bank of America
41
Bank of America
North Carolina
$46K -$136K -2,100 -78%
RFA
42
Reilly Financial Advisors
California
$31K – – –
Fifth Third Bancorp
43
Fifth Third Bancorp
Ohio
$10K – – –
TRCT
44
Tower Research Capital (TRC)
New York
$8K -$18.3K -282 -74%
FWM
45
Focused Wealth Management
New York
$8K +$6.49K +100 New
Deutsche Bank
46
Deutsche Bank
Germany
$7K -$267K -4,115 -98%
AllianceBernstein
47
AllianceBernstein
Tennessee
$2K +$1.3K +20 New
AA
48
Ancient Art
Texas
– -$4.92M -87,980 Closed
Two Sigma Investments
49
Two Sigma Investments
New York
– -$568K -10,168 Closed
PMG
50
ProVise Management Group
Florida
– -$243K -4,347 Closed
1
2
3

TARO Hedge Fund Activity: Q3 2013 in Review

47 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q3 2013, worth a combined $219M — up 62% from $136M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new TARO positions and 4 closed out — a net gain of 13 holders — while 11 added to existing stakes and 13 trimmed.

The largest buyer was Hotchkis & Wiley Capital Management, opening a new position worth an estimated $28.5M. The largest seller was Raging Capital Management, cutting an estimated $14.7M.

  • 47 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q3 2013, up from 34 in Q2 2013.
  • Funds reported $219M of Taro Pharmaceutical Industries Ltd. stock for Q3 2013, up 62% quarter-over-quarter.
  • 17 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q3 2013 and 4 closed out, a net change of +13 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q3 2013 was Hotchkis & Wiley Capital Management, an estimated $28.5M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q3 2013 was Raging Capital Management, an estimated $14.7M sold.

Based on aggregated 13F filings for Q3 2013.